Belite Bio Inc. - ADRBLTE

13F holders, Q1 2024 (March 31)
11holders
1famous investor
$38.37avg. 13F price*

At the end of Q1 2024, 11 institutions reported holding Belite Bio Inc. - ADR (BLTE) in their 13F filings. The largest holders were State Street Corp. ($640K), Marshall Wace, LLP ($406K) and Point72 Asset Management ($334K). One famous investor held it Steve Cohen (0.0% of Point72 Asset Management's portfolio).

Company
Belite Bio Inc. - ADR
CUSIP
07782B104
Latest filing quarter
Q2 2026

History

Number of 13F holders

020406080 Q1 2024: 11Q1 2024Q2 2024: 11Q2 2024Q3 2024: 15Q3 2024Q4 2024: 22Q4 2024Q1 2025: 18Q1 2025Q2 2025: 18Q2 2025Q3 2025: 34Q3 2025Q4 2025: 69Q4 2025Q1 2026: 75Q1 2026Q2 2026: 80Q2 2026

Total Exit/New Position Q1 2024

InstitutionsTotal Value
New Positions0$0
Exits6$2.2M

Ownership 11 holders

State Street Corp. 0.00% Reduce -5.0% 16,670 $640K
Marshall Wace, LLP 0.00% Reduce -33.9% 10,584 $406K
Point72 Asset Management 0.00% Add +13.0% 8,700 $334K
Geode Capital Management, LLC 0.00% No change 6,700 $257K
Morgan Stanley 0.00% Reduce -72.8% 6,090 $234K
Cubist Systematic Strategies, LLC 0.00% Reduce -71.6% 4,788 $184K
Virtus Advisers, LLC 0.04% Reduce -6.5% 1,959 $75K
Bank of America Corp. 0.00% Reduce -21.9% 1,724 $66K
JPMorgan Chase & Co. 0.00% Reduce -95.4% 658 $25K
GAMMA Investing LLC 0.00% Add +17.6% 234 $9K
Osaic Holdings, Inc. 0.00% Reduce -86.1% 5 $192

"% of holder's portfolio" is BLTE's weight in each manager's 13F, not the share of Belite Bio Inc. - ADR the manager owns.